Watson-Marlow has held a ground breaking ceremony for its new US manufacturing facility in Devens, Massachusetts.
The 150 000 sq ft (14 000 sq m) facility, which will focus on a number of products including peristaltic pumps, tubing, fluid path solutions and BioPure components, is due to be completed in late 2022 with first customer deliveries expected before the end of the year.
Watson-Marlow’s new US facility, which will be located close to the Boston area life sciences hub, will have a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing and offices, along with space for two further cleanrooms. With segregated cleanroom and non-cleanroom production capabilities, Watson-Marlow says that the new US facility will strengthen the support that it will be able to provide to customers in the region across the pharmaceutical and biotechnology, medical diagnostics and process industries.
“The new US facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region,” said Andrew Mines, Watson-Marlow managing director. “This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water.”
